Our Recommendations
- Dementia mhGAP module (2017)
- Depression: Powerpoint Presentation slides (mhGAP) (2015)
- Pharmacological interventions in adolescents with psychotic disorders (2015)
- MhGAP Child and adolescent mental and behavioural disorders, slides. (2010)
- Other significant mental health complaints: mhGAP Training of Health-care Providers and training manual, supporting material (2015)
New Publications
- Керівництво mhGAP версія 2.0 для ведення психічних, неврологічних розладів і розладів, пов'язаних зі вживанням психоактивних речовин, у неспеціалізованих закладах охорони здоров'я (2020)
- Formation des prestataires de soins de santé au Guide d’intervention humanitaire mhGAP(GIH-mhGAP) (2023)
- Formation des prestataires de soins de santé au Guide d’intervention humanitaire mhGAP(GIH-mhGAP) (2023)
- Formation des prestataires de soins de santé au Guide d’intervention humanitaire mhGAP(GIH-mhGAP) (2023)
- EQUIP - Ensuring Quality in Psychological Support (2022)
Filter
64
Featured
Recommendations
14
New Publications
3
Language
Document type
No document type
42
Training Material
10
Manuals
6
Fact sheets
3
Guidelines
2
Resource Platforms
1
Countries / Regions
Western and Central Europe
2
Russia
2
Authors & Publishers
Publication Years
Category
Capacity Building
2
What can you expect?
As a future facilitator your role will be to learn about the structure of mhGAP-IG, how to teach the materials and utilize opportunities to prastice facilitation and supervision skills.
As a supervisor your role will be to serve as a point of reference for non-specialized heal...
Q 1: Are antidepressants (Tricyclic Antidepressants (TCA) and Selective Serotonin Reuptake Inhibitors (SSRI)) better (more
effective than/as safe as) than treatment as usual (placebo) in adults with depressive episode/disorder?
Q 2: How long should treatment with antidepressants continue in adults with depressive episode/disorder?
Q 3: Is brief, structured psychological treatment in non-specialist health care settings better (more effective than/as safe as) than treatment as usual in people with depressive episode/disorder?
Q9: Antidepressant medicines in individuals with a depressive episode in bipolar disorder1Q9: In individuals presenting with a depressive episode in bipolar disorder, are antidepressant medicines effective and safe?
Q10: In individuals with psychotic disorders (including schizophrenia) and bipolar disorders are psychoeducation, family interventions and cognitive-behavioural therapy feasible and effective?
Q 10: In adults and children with epilepsy, which psychological interventions used as adjunctive therapies with antiepileptic drugs when compared to placebo/comparator produce benefits/harm in specified outcomes?
Q9. In adults and children with convulsive epilepsy in remission, when should treatment be discontinued?
Q6: What is the added advantage of doing neuroimaging in people with convulsive epilepsy in non-specialist settings in low and middle income countries?
Q3: Can febrile seizures (simple or complex) be managed at first or second level care by non-specialist health care providers in low and middle income country settings? What is the role of diagnostic tests in the management of febrile seizures by non-specialists in low and middle income settings? Fo...
Q5: What is the added advantage of doing an electroencephalography (EEG) in people with convulsive epilepsy in non- specialist settings in low and middle income countries?
Q4: Can convulsive epilepsy be diagnosed at first level care by a non-specialist health care provider in low and middle income country settings?
Q 4: Is behavioural activation better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?brief, structured psychological treatment in non-specialist health care settings better (more effective than/as safe as) than treatment as usual in people with de...
The number of general health staff skilled in psychological treatment for depression is limited, and learning psychological treatments tends to require considerable training and supervision. Relaxation may be a relatively simple form of psychological treatment. It has been frequently studied in rese...
Q6: Is advice on physical activity better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder with inactive lifestyles
Q1: In individuals with psychotic disorders (including schizophrenia), are antipsychotic drugs safe and effective?
Q2: In individuals with psychotic disorders (including schizophrenia), is the use of two or more antipsychotic medications concurrently more effective and safer than the use of one antipsychotic only?
Q3: In individuals with a first psychotic episode with full remission, how long should antipsychotic drug treatment be continued after remission in order to allow for the best outcomes?
Q4: In individuals with long term and/or recurrent psychotic disorders (including schizophrenia), should individuals be maintained on pharmacotherapy indefinitely or withdrawn from treatment in order to allow for the best outcomes?
Q6: In individuals with psychotic disorders (including schizophrenia) who require long term antipsychotic treatment, are anticholinergic medications more effective in preventing or reducing extrapyramidal side-effects and/or improving treatment adherence than placebo/treatment as usual?
